We are live on
!
Find out more
VFA
Values First Advisors Portfolio holdings
AUM
$192M
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+7.03%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$184M
AUM Growth
+$17.5M
(+10%)
Cap. Flow
+$9.3M
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
280
New
111
Increased
59
Reduced
98
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$7.53M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$4.72M |
| 3 |
Graco
GGG
|
+$1.94M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.24M |
| 5 |
Axsome Therapeutics
AXSM
|
+$552K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$7.66M |
| 2 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$4.4M |
| 3 |
Cintas
CTAS
|
+$1.95M |
| 4 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$781K |
| 5 |
Trane Technologies
TT
|
+$570K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.8% |
| 2 | Technology | 14.19% |
| 3 | Industrials | 10.88% |
| 4 | Real Estate | 7.32% |
| 5 | Consumer Discretionary | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Constellation Energy
CEG
$98B
| $82.6K | 0.04% |
+318
| New | +$63.2K |
|
202
Cabot Corp
CBT
$4.65B
| $81.8K | 0.04% |
+732
| New | +$72.9K |
|
203
Sempra
SRE
$60.8B
| $80.8K | 0.04% |
+966
| New | +$77.3K |
|
204
NetApp
NTAP
$32.9B
| $80.5K | 0.04% |
652
-1,458
| -69% | -$182K |
|
205
Central Garden & Pet Co Class A
CENTA
$2.41B
| $78.9K | 0.04% |
2,511
-42
| -2% | -$1.4K |
|
206
Biohaven
BHVN
$2.16B
| $78.2K | 0.04% |
+1,565
| New | +$60.9K |
|
|
INZY
207
DELISTED
Inozyme Pharma
INZY
| $76.9K | 0.04% |
14,695
-2,372
| -14% | -$12.3K |
|
208
Relay Therapeutics
RLAY
$4.02B
| $74.9K | 0.04% |
+10,579
| New | +$79K |
|
209
IDEAYA Biosciences
IDYA
$3.41B
| $74.3K | 0.04% |
+2,345
| New | +$88.9K |
|
210
Motorola Solutions
MSI
$69.4B
| $73.8K | 0.04% |
+164
| New | +$68.4K |
|
211
Bruker
BRKR
$9.2B
| $73.2K | 0.04% |
+1,060
| New | +$68.5K |
|
212
RLI Corp
RLI
$5.68B
| $69.8K | 0.04% |
+902
| New | +$66.7K |
|
213
Eli Lilly
LLY
$1.07T
| $68.9K | 0.04% |
+78
| New | +$70.1K |
|
214
Lexeo Therapeutics
LXEO
$366M
| $67.3K | 0.04% |
+7,446
| New | +$88.8K |
|
215
Repligen
RGEN
$7.44B
| $62.5K | 0.03% |
+420
| New | +$60.2K |
|
216
Dyne Therapeutics
DYN
$4.04B
| $61.8K | 0.03% |
+1,720
| New | +$68.5K |
|
217
Kymera Therapeutics
KYMR
$9.1B
| $61.3K | 0.03% |
+1,296
| New | +$57.2K |
|
218
iShares Silver Trust
SLV
$28.1B
| $61.2K | 0.03% |
+2,154
| New | +$57.9K |
|
219
Sarepta Therapeutics
SRPT
$1.66B
| $58.8K | 0.03% |
+471
| New | +$65.1K |
|
220
TG Therapeutics
TGTX
$8.58B
| $58.4K | 0.03% |
+2,496
| New | +$54.5K |
|
221
Nektar Therapeutics
NKTR
$2.39B
| $58.2K | 0.03% |
2,984
-29
| -1% | -$553 |
|
222
VanEck Video Gaming and eSports ETF
ESPO
$235M
| $57.8K | 0.03% |
+760
| New | +$52.7K |
|
223
4D Molecular Therapeutics
FDMT
$526M
| $57.5K | 0.03% |
+5,315
| New | +$88.2K |
|
224
BridgeBio Pharma
BBIO
$16.5B
| $57K | 0.03% |
+2,237
| New | +$58.7K |
|
|
CTRA
225
DELISTED
Coterra Energy
CTRA
| $56.9K | 0.03% |
+2,375
| New | +$58.6K |
|
Similar funds
KWM
SCGDR
KC
CVSC
CA
WIA
AGA
LFIA
Values First Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Values First Advisors held 280 positions worth $184M, up 10% from $167M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Values First Advisors deployed $9.3M of net new capital in Q3 2024, opening 111 new positions and adding to 59 existing holdings. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 156,350 shares worth $7.61M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $7.66M trimmed.
- Values First Advisors's largest Q3 2024 buy was iShares Core 1-5 Year USD Bond ETF: 156,350 shares worth $7.61M.
- Values First Advisors added most to Vanguard Short-Term Treasury ETF in Q3 2024, an estimated $4.72M increase.
- Values First Advisors's biggest Q3 2024 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $7.66M.
- Values First Advisors fully exited Cintas in Q3 2024, selling an estimated $1.95M.
- Values First Advisors's ten largest holdings make up 29% of its $184M portfolio in Q3 2024.
- Values First Advisors opened 111 new positions and closed 8 in Q3 2024.
- Values First Advisors's portfolio value rose 10% quarter-over-quarter to $184M.
Based on Values First Advisors's 13F filing for Q3 2024, filed 23 Oct 2024.